These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
717 related articles for article (PubMed ID: 28544786)
1. MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis. Lou G; Yang Y; Liu F; Ye B; Chen Z; Zheng M; Liu Y J Cell Mol Med; 2017 Nov; 21(11):2963-2973. PubMed ID: 28544786 [TBL] [Abstract][Full Text] [Related]
2. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation. Qu Y; Zhang Q; Cai X; Li F; Ma Z; Xu M; Lu L J Cell Mol Med; 2017 Oct; 21(10):2491-2502. PubMed ID: 28382720 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy. Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848 [TBL] [Abstract][Full Text] [Related]
4. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway. Lou G; Chen L; Xia C; Wang W; Qi J; Li A; Zhao L; Chen Z; Zheng M; Liu Y J Exp Clin Cancer Res; 2020 Jan; 39(1):4. PubMed ID: 31898515 [TBL] [Abstract][Full Text] [Related]
6. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. Lou G; Song X; Yang F; Wu S; Wang J; Chen Z; Liu Y J Hematol Oncol; 2015 Oct; 8():122. PubMed ID: 26514126 [TBL] [Abstract][Full Text] [Related]
7. sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p. Kim J; Lee C; Shin Y; Wang S; Han J; Kim M; Kim JM; Shin SC; Lee BJ; Kim TJ; Jung Y Mol Ther; 2021 Apr; 29(4):1471-1486. PubMed ID: 33348053 [TBL] [Abstract][Full Text] [Related]
8. Adipose-derived mesenchymal stem cells inhibit activation of hepatic stellate cells in vitro and ameliorate rat liver fibrosis in vivo. Yu F; Ji S; Su L; Wan L; Zhang S; Dai C; Wang Y; Fu J; Zhang Q J Formos Med Assoc; 2015 Feb; 114(2):130-8. PubMed ID: 25678175 [TBL] [Abstract][Full Text] [Related]
9. Effects of Mesenchymal Stem Cells-Derived Extracellular Vesicles on Inhibition of Hepatic Fibrosis by Delivering miR-200a. Xu AL; Han L; Yan J; Liu D; Wang W Tissue Eng Regen Med; 2024 Jun; 21(4):609-624. PubMed ID: 38568409 [TBL] [Abstract][Full Text] [Related]
10. Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis. Yuan M; Yao L; Chen P; Wang Z; Liu P; Xiong Z; Hu X; Li L; Jiang Y Int Immunopharmacol; 2023 Dec; 125(Pt A):111134. PubMed ID: 37918086 [TBL] [Abstract][Full Text] [Related]
11. [Effect of adipose tissue-derived mesenchymal stem cell transplantation in treatment of liver fibrosis and possible mechanism]. Tang WP; Hu Q; Dai XM; He GS; Luo JX Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):28-33. PubMed ID: 29804359 [No Abstract] [Full Text] [Related]
12. MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2. Wu JC; Chen R; Luo X; Li ZH; Luo SZ; Xu MY World J Gastroenterol; 2019 Aug; 25(31):4468-4480. PubMed ID: 31496625 [TBL] [Abstract][Full Text] [Related]
14. Human Umbilical Cord Mesenchymal Stem Cells Ameliorate Hepatic Stellate Cell Activation and Liver Fibrosis by Upregulating MicroRNA-455-3p through Suppression of p21-Activated Kinase-2. Zhou Q; Gu T; Zhang Y; Li H; Zhuansun X; Xu S; Kuang Y Biomed Res Int; 2021; 2021():6685605. PubMed ID: 33708992 [TBL] [Abstract][Full Text] [Related]
15. Fibrogenic Signaling Is Suppressed in Hepatic Stellate Cells through Targeting of Connective Tissue Growth Factor (CCN2) by Cellular or Exosomal MicroRNA-199a-5p. Chen L; Chen R; Velazquez VM; Brigstock DR Am J Pathol; 2016 Nov; 186(11):2921-2933. PubMed ID: 27662798 [TBL] [Abstract][Full Text] [Related]
16. Improvement of portal venous pressure in cirrhotic rat livers by systemic treatment with adipose tissue-derived mesenchymal stromal cells. Brückner S; Zipprich A; Hempel M; Thonig A; Schwill F; Roderfeld M; Roeb E; Christ B Cytotherapy; 2017 Dec; 19(12):1462-1473. PubMed ID: 29074333 [TBL] [Abstract][Full Text] [Related]
17. Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells. Chen L; Yao X; Yao H; Ji Q; Ding G; Liu X FASEB J; 2020 Apr; 34(4):5178-5192. PubMed ID: 32061112 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression. Hyun J; Wang S; Kim J; Rao KM; Park SY; Chung I; Ha CS; Kim SW; Yun YH; Jung Y Nat Commun; 2016 Mar; 7():10993. PubMed ID: 27001906 [TBL] [Abstract][Full Text] [Related]
19. miR-200c Accelerates Hepatic Stellate Cell-Induced Liver Fibrosis via Targeting the FOG2/PI3K Pathway. Ma T; Cai X; Wang Z; Huang L; Wang C; Jiang S; Hua Y; Liu Q Biomed Res Int; 2017; 2017():2670658. PubMed ID: 28691020 [TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles-derived miR-150-5p secreted by adipose-derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis. Du Z; Wu T; Liu L; Luo B; Wei C J Cell Mol Med; 2021 Jan; 25(2):701-715. PubMed ID: 33342075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]